About this trial
The goal of this campaign is to reduce unnecessary visits to a Geisinger emergency department (ED). In this campaign, patients will be assigned to receive or not receive outreach following ED discharge with a low-acuity visit designation. Outreach will occur via a text message the day after discharge from the ED as well as information added to the patient's after visit summary (AVS). Depending on the assigned condition, it will include calls to see their primary care provider (PCP) or use an Intelligent Triage tool. The study will assess whether ED use within the following 120 days differs across patients in different outreach conditions (current standard practice vs contact your PCP vs use Intelligent Triage). It will also examine whether patients follow through on the message-specific calls to action differently across conditions.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
>= 18 years of age
Geisinger ED visit rated as low acuity (L4 or L5)
Discharged from Geisinger ED in past 24 hours
Disqualifiers
Cannot be contacted via the communication modality being used in the study (i.e., SMS), due to insufficient/missing contact information in the EHR or because the patient opted out
Admitted to hospital
Already included in intervention in past 365 days
Trial design
Parallel
Treatments tested in this trial
Contact your PCP
BehavioralText messages will be sent and discharge paperwork will be modified to encourage contacting a primary care provider.
Use Intelligent Triage
BehavioralText messages will be sent and discharge paperwork will be modified to encourage using Intelligent Triage.
Treatment groups
Trial outcomes
Primary outcomes
Return to Geisinger ED
ED visit (yes/no)
Other outcomes
PCP appointment made
PCP appointment made (yes/no)
PCP visit
PCP appointment attended (yes/no)
Telehealth appointment made
Telehealth appointment made (yes/no)
Telehealth appointment attended
Telehealth appointment attended (yes/no)
Sponsors and contacts
Click on the lead sponsor to view all of their trials.